Literature DB >> 32002739

Breakthrough cancer pain: review and calls to action to improve its management.

C Camps Herrero1, N Batista2, N Díaz Fernández3, Y Escobar Álvarez4, A Gonzalo Gómez5, D Isla Casado6, A Salud7, J Terrasa Pons8, V Guillem Porta9.   

Abstract

In this paper, we review the current state of breakthrough cancer pain (BTcP) management. BTcP is a heterogeneous condition and a global problem for cancer patients. It is often managed suboptimally, which results in a negative outcome for patients, healthcare providers, and healthcare systems. Several barriers to the appropriate management of BTcP have been identified. These include, among others, an incomplete definition of BTcP, poor training of healthcare providers and patients alike, a lack of a multidisciplinary approach and the absence of specific protocols and tools. We provide some actions to help physicians and patients improve their approach to BTcP, including specific training, the design of easy-to-use tools for BTcP identification and assessment (such as checklists and pocket-sized cards), individualized treatment, and the use of multidisciplinary teams.

Entities:  

Keywords:  Actions; Approach; Barriers; Breakthrough cancer pain

Year:  2020        PMID: 32002739     DOI: 10.1007/s12094-019-02268-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  4 in total

1.  Efficacy of adenosylmethionine combined with Si Mo Tang in treatment of neonatal jaundice.

Authors:  Ling Li; Jingqun Wang; Shuxia Geng; Fang Liu; Lili Ping; Xiaohong Gu; Xueai Fan; Mei Yang; Lixia Liang; Wei Guo
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma.

Authors:  Russell F Palm; Heather S L Jim; David Boulware; Peter A S Johnstone; Arash O Naghavi
Journal:  Clin Transl Radiat Oncol       Date:  2020-02-28

3.  Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study.

Authors:  Arturo Cuomo; Marco Cascella; Cira Antonietta Forte; Sabrina Bimonte; Gennaro Esposito; Stefano De Santis; Luigi Cavanna; Flavio Fusco; Mario Dauri; Silvia Natoli; Marco Maltoni; Alessandro Morabito; Rocco Domenico Mediati; Vito Lorusso; Sandro Barni; Giampiero Porzio; Sebastiano Mercadante; Anna Crispo
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.964

4.  Strengths and Weaknesses of Cancer Pain Management in Italy: Findings from a Nationwide SIAARTI Survey.

Authors:  Marco Cascella; Alessandro Vittori; Emiliano Petrucci; Franco Marinangeli; Antonino Giarratano; Cristina Cacciagrano; Emiliano Simone Tizi; Luca Miceli; Silvia Natoli; Arturo Cuomo
Journal:  Healthcare (Basel)       Date:  2022-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.